257 related articles for article (PubMed ID: 22892601)
21. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
22. Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma.
Zhong M; De Angelo P; Osborne L; Keane-Tarchichi M; Goldfischer M; Edelmann L; Yang Y; Linehan WM; Merino MJ; Aisner S; Hameed M
Am J Surg Pathol; 2010 Jun; 34(6):757-66. PubMed ID: 20421778
[TBL] [Abstract][Full Text] [Related]
23. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.
Martignoni G; Pea M; Gobbo S; Brunelli M; Bonetti F; Segala D; Pan CC; Netto G; Doglioni C; Hes O; Argani P; Chilosi M
Mod Pathol; 2009 Aug; 22(8):1016-22. PubMed ID: 19396149
[TBL] [Abstract][Full Text] [Related]
24. Renal translocation carcinoma with expression of TFEB: presentation of a case with distinctive histological and immunohistochemical features.
Suárez-Vilela D; Izquierdo-García F; Méndez-Álvarez JR; Miguélez-García E; Domínguez-Iglesias F
Int J Surg Pathol; 2011 Aug; 19(4):506-9. PubMed ID: 19687027
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological study of 5 cases of renal cell carcinoma with t(6;11)(p21;q12).
Kuroda N; Yorita K; Sasaki N; Ishihara A; Matsuura K; Daa T; Mori S; Sasaki A; Mikami S; Shigematsu K; Nagashima Y
Pol J Pathol; 2017; 68(1):66-72. PubMed ID: 28547982
[TBL] [Abstract][Full Text] [Related]
26. Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects.
Kuroda N; Tanaka A; Sasaki N; Ishihara A; Matsuura K; Moriyama M; Nagashima Y; Inoue K; Petersson F; Martignoni G; Michal M; Hes O
Histol Histopathol; 2013 Jun; 28(6):685-90. PubMed ID: 23426439
[TBL] [Abstract][Full Text] [Related]
27. TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.
Caliò A; Harada S; Brunelli M; Pedron S; Segala D; Portillo SC; Magi-Galluzzi C; Netto GJ; Mackinnon AC; Martignoni G
Mod Pathol; 2021 Apr; 34(4):842-850. PubMed ID: 33208882
[TBL] [Abstract][Full Text] [Related]
28. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas.
Harada S; Caliò A; Janowski KM; Morlote D; Rodriguez Pena MD; Canete-Portillo S; Harbi D; DeFrank G; Magi-Galluzzi C; Netto GJ; Martignoni G; Mackinnon AC
Mod Pathol; 2021 Nov; 34(11):2055-2063. PubMed ID: 34148064
[TBL] [Abstract][Full Text] [Related]
30. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.
Skala SL; Xiao H; Udager AM; Dhanasekaran SM; Shukla S; Zhang Y; Landau C; Shao L; Roulston D; Wang L; Siddiqui J; Cao X; Magi-Galluzzi C; Zhang M; Osunkoya AO; Smith SC; McKenney JK; Betz BL; Myers JL; Chinnaiyan AM; Tomlins SA; Mehra R
Mod Pathol; 2018 Jan; 31(1):179-197. PubMed ID: 28840857
[TBL] [Abstract][Full Text] [Related]
31. Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification.
Lin R; Flerova E; Wamsley CE; McCue PA; Lallas CD; Jiang W; Huang J; Wang ZX; Li L
Genes Chromosomes Cancer; 2023 Jun; 62(6):353-360. PubMed ID: 36704911
[TBL] [Abstract][Full Text] [Related]
32. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract][Full Text] [Related]
33. A Tale of 2 Morphologies: Diagnostic Pitfalls in
Sharma AE; Parilla M; Wanjari P; Segal JP; Antic T
Int J Surg Pathol; 2021 Feb; 29(1):21-29. PubMed ID: 32886007
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
[No Abstract] [Full Text] [Related]
35. Histological and molecular characterization of TFEB-rearranged renal cell carcinomas.
Wyvekens N; Rechsteiner M; Fritz C; Wagner U; Tchinda J; Wenzel C; Kuithan F; Horn LC; Moch H
Virchows Arch; 2019 May; 474(5):625-631. PubMed ID: 30706129
[TBL] [Abstract][Full Text] [Related]
36. PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.
Xiong L; Chen X; Liu N; Wang Z; Miao B; Gan W; Li D; Guo H
PLoS One; 2017; 12(9):e0185337. PubMed ID: 28949976
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution.
Kuiper RP; Schepens M; Thijssen J; van Asseldonk M; van den Berg E; Bridge J; Schuuring E; Schoenmakers EF; van Kessel AG
Hum Mol Genet; 2003 Jul; 12(14):1661-9. PubMed ID: 12837690
[TBL] [Abstract][Full Text] [Related]
38. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X
Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774
[TBL] [Abstract][Full Text] [Related]
39. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.
Davis IJ; Hsi BL; Arroyo JD; Vargas SO; Yeh YA; Motyckova G; Valencia P; Perez-Atayde AR; Argani P; Ladanyi M; Fletcher JA; Fisher DE
Proc Natl Acad Sci U S A; 2003 May; 100(10):6051-6. PubMed ID: 12719541
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma.
Kim SH; Choi Y; Jeong HY; Lee K; Chae JY; Moon KC
Virchows Arch; 2011 Sep; 459(3):299-306. PubMed ID: 21773754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
